In-vitro Diagnostics Market Revenue to hit $95 Billion by 2025: Global Market Insights, Inc.

SELBYVILLE, Delaware, Aug. 6, 2019 /PRNewswire/ -- North America in-vitro diagnostics market is expected to witness over 5% CAGR. Increasing burden of viral infection and chronic diseases have surged the demand for in-vitro diagnostics in the region. Furthermore, presence of Medicare and Medicaid facilities for effective health management and awareness among people regrading early and reliable disease diagnosis should foster the business growth.

Laboratories segment of in-vitro diagnostics market accounted for over 29% revenue share in 2018 owing to growing number of well-equipped laboratories delivering superior quality diagnostic services. Surge in the number of laboratories that strive to provide accurate diagnostic decisions will increase the demand for advanced and innovative technologies within the diagnostic devices, thereby, augmenting in-vitro diagnostics business growth.

Request for a sample of this research report @

Infectious diseases segment was valued more than 15 billion in 2018 and is expected to experience momentous growth during analysis period. Segment growth is attributed to rising prevalence of salmonella infections that typically develops due to infection in the intestinal tract. Increasing demand for in-vitro diagnostics in effective diagnosis of infectious diseases will favor segmental growth.

Worldwide In-vitro Diagnostics Market is anticipated to surpass USD 95 billion by 2025; according to a new research report by Global Market Insights, Inc. Rapidly growing demand for automated laboratory machines and equipment primarily will drive in-vitro diagnostics (IVD) industry growth. Adoption of advanced technologies in developed countries has led to modifications in the medical diagnostic machinery and equipment. Also, developed economies have focused their attempts on R&D activities to manufacture automated laboratory equipment for accurate disease detection. Rising implementation of advanced diagnostic machinery should augment in vitro diagnostics business growth. Moreover, specific regulations laid by European Diagnostic Clusters Alliance (EDCA), on the manufacturers of IVD tools to meet patient's safety will prove beneficial for the industry growth.

Growing preference towards personalized medication for the treatment of several chronic disorders will render positive impact on in-vitro diagnostics market. Benefits delivered by personalized treatment and medicines including optimal dosing, accurate and target treatment along with early intervention will surge its demand over the coming years. Additionally, extensive usage of in vitro diagnostics to develop new therapies to treat different chronic diseases on molecular level is expected to further propel business growth. However, unfavorable reimbursement scenario may restrict in-vitro diagnostics business growth during the analysis timeframe.

Browse key industry insights spread across 244 pages with 342 market data tables & 10 figures & charts from the report, "In-vitro Diagnostics Market Size By Type (Product [Reagents & Kits, Instruments], Service [Software, Testing Services]), By Technology (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics) By End-user (Hospitals, Point of Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025" in detail along with the table of contents:

Product segment of in-vitro diagnostics market was valued over 17 billion in 2018 and will witness lucrative growth during the analysis period. Product improvizations and high utilization of reagents and kits in diagnosis of viral infections and other hormonal disorders including hyperthyroidism will favor segmental growth. Moreover, focus of manufacturers on developing superior quality reagents for accurate disease diagnosis will accelerate the demand for IVD products, thereby, should upsurge the business growth.

Clinical chemistry segment accounted for around 20% revenue share in 2018 and will show substantial CAGR by 2025. Wide usage of clinical chemistry in development of novel therapies to eradicate the gene-level diseases including cystic fibrosis, sickle cell anemia and Huntington's disease will boost segmental growth over the analysis period.

Some of the eminent business players operating in in-vitro diagnostics market include Qiagen, Becton Dickinson, Abbott, Cephied, Johnson & Johnson, BioRad, Grifols, Danaher, Siemens, Luminex, Roche Diagnostics, Thermo Fisher Scientific, Sorin, and BioMerieux. Business players focus on various strategic initiatives to improve their revenue share and strengthen market position. For instance, in March 2018, Danaher acquired Integrated DNA Technologies. This strategic acquisition enabled company to broaden its customer base and gain more revenue. Furthermore, in May 2018, Abbott introduced Afinion 2 analyzer, a rapid test system for diabetes management to enhance its existing product portfolio and capitalize over market opportunities.

Make an inquiry for purchasing this report @

Browse Related Reports:

In-vitro Diagnostic Services Market By Service Type {Software (Standalone Software, Software Update), Testing Services (Infectious Testing, Diabetes Testing, Molecular Testing, Tissue Testing)}, By End-user (Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

In-vitro Fertilization Services Market By Procedure (In-vitro Fertilization, Intracytoplasmic Sperm Injection), By Age Group (Below 34, 35-39, 40-42, 43 and Above), By End-use (Hospitals, Fertility Centers, Surgical Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Poland, Greece, Japan, China, India, Australia, South Korea, Argentina, Brazil, Mexico, Israel, Egypt), Application Potential, Competitive Market Share & Forecast, 2019 - 2025

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: +1-302-846-7766
Toll Free: 1-888-689-0688
Connect with us: Facebook | LinkedIn | Twitter

View original content:

SOURCE Global Market Insights, Inc.